FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

RPGLIFE

268.8
+4 (1.51%)
Updated 03:28 02/07 IST

RPGLIFE Buy or Sell - FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 5,328 for RPGLIFE
Disclaimer
100% Bullish
0% Bearish

RPGLIFE Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See RPGLIFE Share Price Targets >>

RPGLIFE Ratings

Long term RPGLIFE rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live RPGLIFE message board: Is RPGLIFE buy or sell? Should I buy RPGLIFE shares? Why are RPGLIFE shares falling? Should I invest in RPGLIFE stock?

  1. Home
  2. RPGLIFE Forum

RPGLIFE Share Price Discussion


Type
Buy
Instrument
RPGLIFE
Entry Price
₹266.4
Price@Trade
₹266.4
Target Price
₹290
Stop Price
₹260
Valid Till
Jul 8, 2020 3:20 AM
Margin
₹5,328 approx for 20 Qty
Status
Active
Like
Reply
R
Reputation: 2,241 • May 27 5:09 AM

Type
Buy
Instrument
RPGLIFE
Entry Price
₹237
Price@Trade
₹236.5
Target Price
₹290
Stop Price
₹231  ₹250
Valid Till
May 27, 2021 3:20 AM
Margin
₹23,700 approx for 100 Qty
Status
Exited
Exit Price
₹251
Net P&L
+₹1,400 (+5.91%)
Like
Reply (3)
Latest replies
TrackerBot @trackerbot
May 27 5:12 AM

Update
Trade Entered
Entry Price
₹237
ROHAN @rohan9401
May 29 7:30 AM

Update
Stoploss Trailed
Price @ Update
₹253
Original SL
₹231
New SL
250.0
ROHAN @rohan9401
May 29 8:01 AM

Update
Exited
Exit Price
₹251
Net P&L
+₹1,400 (+5.91%)
N
Reputation: 3,757 • Apr 18 3:23 AM
Overcoming all COVID-19 odds, this pharma company delivered life-saving medicine to patients
Yugal Sikri, Managing Director, RPG Life Sciences narrated the unprecedented chaos and disruption his company has to go through to bring a life-saving medication Azathioprine to patients in India.
Moneycontrol
Like
Reply
N
Reputation: 3,757 • Mar 17 2:08 AM
Trade Setup for Wednesday: Top 15 things to know before Opening Bell
The key support level for Nifty is placed at 8787.17, followed by 8607.28. If the index moves up, key resistance levels to watch out for are 9275.37 and 9583.68.
Moneycontrol
Like
Reply
N
Reputation: 3,757 • Feb 4 3:43 AM
RPG Life Sciences banking on legacy brands and new launches
Managing Director Yugal Sikri expressed confidence about keeping up the growth momentum.
Moneycontrol
Like
Reply
N
Reputation: 3,757 • Jan 31 3:38 AM
Domestic biz helped RPG Life Sciences report 49% YoY rise in Q3 net profit
Domestic business constitutes about two-thirds of company’s revenues grew at 23 percent, and international sales that constitute the rest grew by 26 percent.
Moneycontrol
Like
Reply

RPGLIFE - chart - 493214
#GOOD_TO_KNOW
RPG LIFE SCIENCES
Weekly Flag breakout
SUPPORT @312
SL @310
Daily consolidation possible.
Price momentum Up 310_316_324_334_356_372_386_398_412
TARGET 412
CHART FOR STUDY
HOPE FOR THE BEST.
#ABHEYPRAKASH #TEJGYAN #SWINGTRADING #STOCKMARKET #SHAREMARKETTIPS #PROF...
Read more...
Like
Reply
Like
Reply
Like
Reply
Hansraj pandey in RPGLIFE
BUY RPG LIFE BUY AVB 275-76 STOP LOSS 270 B...
Like
Reply

BUY RPG LIFE BUY AVB 275-76 STOP LOSS 270 BELOW TARGET 280/286++
Like
Reply
N
Reputation: 3,757 • Sep 25, 2019 1:33 AM
Lower corporate tax will correct balance sheets, spur investments: Pramod Menon, Group CFO, RPG Enterprises
At RPG Enterprises, the reduced tax rate will help advance some of the capital expenditure, he said.
Moneycontrol
Like
Reply
N
Reputation: 3,757 • Jul 30, 2019 3:23 AM
RPG Life Sciences profit jumps four-fold led by domestic formulation biz growth
Sales of domestic formulation, the biggest contributor to the business grew by 27.5 percent.
moneycontrol.com
Like
Reply

Free call - RPGLIFE blasting. CMP 212-213 #equity #intraday #nse #bse #nifty #sensex
Like
Reply (1)
Latest replies
Neeraj Puri Goswami @neeraj
Jan 30, 2019 6:11 AM

RPGLIFE free call suggested at 212-213. now touched 227.55. Hope you enjoyed this free call

Click here to join our cash intraday service with offer price 999/- for one month

https://front.page/cash-intraday-neerajpurig

Start watching - RPFLIFE now at 235
Like
Reply (1)
Latest replies
Neeraj Puri Goswami @neeraj
Dec 11, 2018 4:43 AM

RPGLIFE was suggested at 235. now touched 241
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • RPGLIFE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization632.74
    Enterprise Value686.02
    Price to Earnings47.04
    Price to Book Value4.09
    Return on Capital Employed0.12
    Return on Equity0.09
    Face Value8
    Dividend Yield0.01
  • RPGLIFE - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    19-Dec-16HDFC SecuritiesBuy601.5
    RPGLIFE Brokerage Price Target
  • RPGLIFE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 2267270.55265266.95
    Jul 1265.05269.7262.2264.8
    Jun 30266.05272.35263.95265.75
    Jun 29268270.7260.8264.5
    Jun 26275275.85268269.1
  • RPGLIFE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹269.52
    30 Day Moving Average₹264.57
    50 Day Moving Average₹255.12
    100 Day Moving Average₹243.1
    200 Day Moving Average₹252.24
  • RPGLIFE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue343.95304.410.13
    Operating Profit38.4429.130.32
    Profit Before Tax20.3622.68-0.1
    Net Income13.4520.46-0.34
  • RPGLIFE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds154.75154.080
    Total Liabilities148.7999.120.5
    Total Assets303.54253.20.2
  • RPGLIFE - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity14.687.540.95
    Cash from Investing Activity-15.54-30.04-0.48
    Cash from Financing Activity0.1123.13-1
    Net Cash Flow-0.750.63-2.19
  • RPGLIFE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.040.08
    Return on Equity0.090.13
    Return on Capital Employed0.120.13
  • RPGLIFE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.42
    3 Year CAGR Growth in Operating Profit1.71
    3 Year CAGR Growth in EBIDTA1.61
    3 Year CAGR Growth in Net Income12.45
    3 Yr CAGR Growth - Diluted EPS12.55
  • RPGLIFE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.55
    5 Year CAGR Growth in Operating Profit1.39
    5 Year CAGR Growth in EBIDTA1.21
    5 Year CAGR Growth in Net Income2.05
    3 Yr CAGR Growth - Diluted EPS2.04
  • RPGLIFE - Recent News

    keyboard_arrow_down
    NewsBot
    Apr 18 3:23 AM
    Overcoming all COVID-19 odds, this pharma company delivered life-saving medicine to patients
    Moneycontrol
    NewsBot
    Mar 17 2:08 AM
    Trade Setup for Wednesday: Top 15 things to know before Opening Bell
    Moneycontrol
    NewsBot
    Feb 4 3:43 AM
    RPG Life Sciences banking on legacy brands and new launches
    Moneycontrol
    NewsBot
    Jan 31 3:38 AM
    Domestic biz helped RPG Life Sciences report 49% YoY rise in Q3 net profit
    Moneycontrol
    NewsBot
    Sep 25, 2019 1:33 AM
    Lower corporate tax will correct balance sheets, spur investments: Pramod Menon, Group CFO, RPG Enterprises
    Moneycontrol
    NewsBot
    Jul 30, 2019 3:23 AM
    RPG Life Sciences profit jumps four-fold led by domestic formulation biz growth
    moneycontrol.com
    NewsBot
    Feb 1, 2019 9:17 AM
  • RPGLIFE - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020